The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers
Abstract
Background and Purpose— Because there is no biologic marker offering precise information about stroke etiology, many patients receive a diagnosis of undetermined stroke even after all available diagnostic tests are done, precluding correct treatment. Methods— To examine the diagnostic value of a panel of biochemical markers to differentiate stroke etiologies, consecutive acute stroke patients were prospectively evaluated. Brain computed tomography, ultrasonography, cardiac evaluations, and other tests were done to identify an etiologic diagnosis according to TOAST classification. Blood samples were drawn on Emergency Department arrival (<24 hours) to test selected biomarkers: C-reactive protein, D-dimer, soluble receptor for advanced glycation end products, matrix metalloproteinase-9, S-100b, brain natriuretic peptide (BNP), neurotrophin-3, caspase-3, chimerin, and secretagogin (assayed by ELISA). Results— Of 707 ischemic stroke patients included, 36.6% were cardioembolic, 21.4% atherothrombotic, 18.1% lacunar, and 23.9% of undetermined origin. High levels of BNP, soluble receptor for advanced glycation end products, and D-dimer ( P <0.0001) were observed in patients with cardioembolic stroke. Independent predictors (odds ratios with CIs are given) of cardioembolic stroke were as follows: atrial fibrillation 15.3 (8.4–27.7, P <0.001); other embolic cardiopathies 14.7 (4.7–46, P <0.001); total anterior circulation infarction 4 (2.3–6.8, P <0.001); BNP >76 pg/mL 2.3 (1.4–3.7, P =0.001); and D-dimer >0.96 μg/mL 2.2 (1.4–3.7, P =0.001). Even among patients with transient symptoms (n=155), a high BNP level identified cardioembolic etiology (6.7, 2.4–18.9; P <0.001). A model combining clinical and biochemical data had a sensitivity of 66.5% and a specificity of 91.3% for predicting cardioembolism. Conclusions— Using a combination of biomarkers may be a feasible strategy to improve the diagnosis of cardioembolic stroke in the acute phase, thus rapidly guiding other diagnostic tests and accelerating the start of optimal secondary prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Epstein, F. H., Levin, E. R., Gardner, D. G., & Samson, W. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390507 · Cited by 1,927
Grant, E. G., Benson, C. B., Moneta, G. L., Alexandrov, A. V., Baker, J. D., Bluth, E. I., Carroll, B. A., Eliasziw, M., Gocke, J., Hertzberg, B. S., et al. (2003) · Radiology · doi:10.1148/radiol.2292030516 · Cited by 1,539
Kolominsky-Rabas, P. L., Weber, M., Gefeller, O., Neundoerfer, B., & Heuschmann, P. U. (2001) · Stroke · doi:10.1161/hs1201.100209 · Cited by 1,281
B-type natriuretic peptide in cardiovascular disease
de Lemos, J. A., McGuire, D. K., & Drazner, M. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13976-1 · Cited by 1,067
Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies
Lovett, J. K., Coull, A. J., & Rothwell, P. M. (2004) · Neurology · doi:10.1212/01.wnl.0000110311.09970.83 · Cited by 741
Montaner, J., Molina, C. A., Monasterio, J., Abilleira, S., Arenillas, J. F., Ribó, M., Quintana, M., & Alvarez-Sabín, J. (2003) · Circulation · doi:10.1161/01.cir.0000046451.38849.90 · Cited by 555
Self-citationCerebral Embolism Task Force (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520010065026 · Cited by 539
Hankey, G. J., & Warlow, C. P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04407-4 · Cited by 513
Treatment of Acute Ischemic Stroke
Brott, T., & Bogousslavsky, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431007 · Cited by 398
Falcone, C., Emanuele, E., D’Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., & Geroldi, D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160342.20342.00 · Cited by 377
Novel Diagnostic Test for Acute Stroke
Lynch, J. R., Blessing, R., White, W. D., Grocott, H. P., Newman, M. F., & Laskowitz, D. T. (2004) · Stroke · doi:10.1161/01.str.0000105927.62344.4c · Cited by 248
Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation
Inoue, S.-I., Murakami, Y., Sano, K., Katoh, H., & Shimada, T. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)90010-1 · Cited by 236
Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation
Inoue, S.-I., Murakami, Y., Sano, K., Katoh, H., & Shimada, T. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.8185 · Cited by 196
Natriuretic Peptides and Mortality After Stroke
Mäkikallio, A. M., Mäkikallio, T. H., Korpelainen, J. T., Vuolteenaho, O., Tapanainen, J. M., Ylitalo, K., Sotaniemi, K. A., Huikuri, H. V., & Myllylä, V. V. (2005) · Stroke · doi:10.1161/01.str.0000162751.54349.ae · Cited by 165
Role and importance of biochemical markers in clinical cardiology
Panteghini, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.026 · Cited by 153
Zanette, E. M., Roberti, C., Mancini, G. B. J., Pozzilli, C., Bragoni, M., & Toni, D. (1995) · Stroke · doi:10.1161/01.str.26.3.430 · Cited by 122
Shimizu, H., Murakami, Y., Inoue, S., Ohta, Y., Nakamura, K., Katoh, H., Sakne, T., Takahashi, N., Ohata, S., Sugamori, T., et al. (2002) · Stroke · doi:10.1161/hs0402.105657 · Cited by 96
Tombul, T., Atbaş, Ç., & Anlar, Ö. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.06.013 · Cited by 65
Vanderheyden, M., Bartunek, Claeys, G., Manoharan, G., Beckers, J. F., & Ide, L. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.01.021 · Cited by 54
Brosnan, M. J., Clark, J. S., Jeffs, B., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.290 · Cited by 41
Nagao, T., Hamamoto, M., Kanda, A., Tsuganesawa, T., Ueda, M., Kobayashi, K., Miyazaki, T., & Terashi, A. (1995) · Stroke · doi:10.1161/01.str.26.8.1365 · Cited by 35
Thrombin generation in non-cardioembolic stroke subtypes
Furie, K. L., ROSENBERG, R. D., Thompson, J. L. P., Bauer, K. A., Mohr, J. P., ROSNER, B. A., Sciacca, R. R., Barzegar, S., Thornell, B. J., Costigan, T., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000137032.20456.df · Cited by 23
Cited by
Turner, R. J., & Sharp, F. R. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00056 · Cited by 533
Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley, W., Chong, W. L., Sengupta, A., & Sandercock, P. (2009) · Stroke · doi:10.1161/strokeaha.108.528752 · Cited by 290
Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Saenger, A. K., & Christenson, R. H. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133801 · Cited by 252
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review
Ramos-Fernandez, M., Bellolio, M. F., & Stead, L. G. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.10.008 · Cited by 220
Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B. I., & Lambert, M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep199 · Cited by 190
Metadata
- Authors
- Montaner, J., Perea-Gainza, M., Delgado, P., Ribó, M., Chacón, P., Rosell, A., Quintana, M., Palacios, M. E., Molina, C. A., & Alvarez-Sabín, J.
- Venue
- Stroke
- Published
- 2008-08
- Volume
- 39
- Issue
- 8
- Pages
- 2280-2287
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2161212353
- Cited by
- 303
- References
- 24
- FWCI
- 15.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.